• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Invesigation on cellular mechanism of erythropoietin induced hypertension

Research Project

Project/Area Number 10671003
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Kidney internal medicine
Research InstitutionJichi Medical School

Principal Investigator

KUSANO Eiji  Jichi Medical School, Div Nephrol, Associate professor, 医学部, 助教授 (50102249)

Co-Investigator(Kenkyū-buntansha) IIMURA Osamu  Jichi Medical School, Div Nephrol, Insturctor, 医学部, 助手 (60265246)
KOMATSU Norio  Jichi Medical School, Div Hematol, Associate professor, 医学部, 助教授 (50186798)
Project Period (FY) 1998 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥1,500,000 (Direct Cost: ¥1,500,000)
Fiscal Year 2000: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 1999: ¥900,000 (Direct Cost: ¥900,000)
Keywordshemodialysis / erythropoietin / hypertension / vascular smooth muscle cell / apoptosis / intracellular calcium / nitric oxide / vasoconstrictive substance / 動脈硬化 / 血管のリモデリング / 透析患者 / サイトカイン / IL-1β / 一酸化窒素合成酵素 / 血管平滑筋細胞
Research Abstract

Erythropoietin (EPO)-induced hypertension in the patients on maintenance hemodialysis is a matter of paticular interest in clinical nephrology. Although various possibility is indicated on the mechanism of the EPO-induced hypertension, we have examined it with special reference to nitric oxide (NO) metabolism in cultured rat vascular smooth muscle cells (VSMC). We already demonstrated that EPO inhibited interleukin -1β induced iNOS mRNA and protein expression and NO production in VSMC.Recent studies have shown that several cytokines could induce apoptosis to VSMC via the induction of NO.In addition, EPO induces cytosolic free calcium ([Ca^<2+>]i) mobilization and also modulates the sensitivity of the cardiovascular system to vasoconsrictive substances such as angiotensin II (AgII), norepinephrine (NE) or endothelin (ET). Therefore, in the present project, we explored whether EPO has a modulatory effect of apoptosis on IL-1β or NO donor sodium nitroprusside (SNP) induced apoptosis in VS … More MC.Furthermore, we explored the mechanism of EPO induced [Ca^<2+>]i mobilization and its role in the activation of MAP kinase and DNA synthesis and explored the effect of EPO on the responsiveness of AgII, NE or ET induced [Ca^<2+>]i mobilization in VSMC.
Our present study demonstrated that rHuEPO inhibited IL-1β or SNP induced VSMC apoptosis. The TK dependent pathway, particularly the PI 3-kinase dependent pathway seems to be critical to the countervailing effect of rHuEPO on IL- 1β and SNP induced VSMC apoptosis.
Concerning the effects of EPO on [Ca^<2+>]i, (1) EPO increases [Ca^<2+>]i by both Ca^<2+> influx and Ca^<2+> release from intracellular stores. Tyrosine phosphorylation is critical in the regulation of [Ca^<2+>]i, but PKC activation is important only in the regulation of Ca^<2+> influx. Dihydoropyridine sensitive L-type Ca^<2+> channel seems to be involved in EPO induced Ca^<2+> influx. In addition, increase of [Ca^<2+>]i by EPO stimulates MAP kinase activation and DNA synthesis in VSMC.Furthermore, EPO has synergistic effects on AgII, NE or ET induced [Ca^<2+>]i mobilization, particularly on intracellular Ca^<2+> release, in VSMC.This may be one of the potential mechanisms that contribute to hypertension associated with EPO therapy. However, further investigations were needed to clarify the effect of lower concentaration of EPO on the dynamics of [Ca^<2+>]i. Less

Report

(4 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • 1998 Annual Research Report
  • Research Products

    (37 results)

All Other

All Publications (37 results)

  • [Publications] Kusano E: "Modulation of endothelin-1 induced cytosolic free calcium mobilization and mitogen-activated protein kinase activation by erythropoietin in vascular smooth muscle cell"Kidney and Blood pressure Res. (in press). (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kusano E: "Hemodialysis and nitric oxide."J Artif Org. (in press). (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Akimoto T: "Involvement of erythropoietin induced cytosolic free calcium mobilization in activation of mitogen-activated protein kinase and DNA synthesis in vascular smooth muscle cells."J Hypertens. 19. 193-202 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Akimoto T: "Erythropoietin modulates angiotensin II or norepinephrine induced Ca2+ mobilization in cultured rat vascular smooth muscle cells."Nephrol Dial Transplant. (in press). (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sasaki N: "Glucocorticoid decreases circulating osteoprotegerin (OPG) : possible mechanism for glucocorticoid induced osteoporosis."Nephrol Dial Transplant. (in press). (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Akimot T: "Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway."Kidney Int. 58. 269-282 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kusano E, Akimoto T, Inoue M, Masunaga Y, Umino T, Ono S, Ando Y, Homma S, Muto S, Komatsu N.Asano Y: "Human recombinant erythropoietin inhibits interleukin-1b-stimulated nitric oxide and cyclic guanosine monophosphate production in cultured rat vascular smoot-muscle cells."Nephrol Dial Transplant. 14. 597-603 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Akimot T, Kusano E, Muto S, Fujita N, Okada K, Saito T, Komatsu N, Ono S.Ebata S, Ando Y, Homma S.Asano Y: "The effect of erythropoietin on interleukin- 1b mediated increase in nitric oxide synthesis in vascular smooth muscle cells."J Hypertension. 17. 1249-1256 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Akimot T, Kusano E, Inaba T, Iimura O, Takahashi H, Ikeda H, Ito C, Ando Y, Ozawa K, Asano Y: "Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway."Kidney Int. 58. 269-282 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Akimoto T, Kusano E, Ito C, Yanagiba S, Inoue M, Amemiya M, Ando Y, Asano Y: "Involvement of erythropoietin induced cytosolic free calcium mobilization in activation of mitogen-activated protein kinase and DNA synthesis in vascular smooth muscle cells."J Hypertens. 19. 193-202 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Akimoto T, Kusano E, Fujita F, Okada K, Saito S, Ono S, Ando Y, Homma S, Saito T, Asano Y.: "Erythropoietin modulates angiotensin II or norepinephrine induced Ca2+ mobilization in cultured rat vascular smooth muscle cells."Nephrol Dial Transplant. (in press). (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kusano E, Akimoto T, Sasaki N, Ando Y, Asano Y.: "Hemodialysis and nitric oxide."J Artif Org. (in press). (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kusano E, Akimoto T, Umino T, Yanagiba S, Inoue M, Ito C, Ando Y, Asano Y.: "Modulation of endothelin- 1 induced cytosolic free calcium mobilization and mitogen-activated protein kinase activation by erythropoietin in vascular smooth muscle cells"Kidney and Blood pressure Res. (in press). (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kusano, E., Masunaga, Y., Akimoto, T., Umino, T., Ono, S., Ando, Y., Homma, S., Asano, Y.: "Recombinant human erythropoietin inhibits interleukin- 1β induced nitric oxide production in cultured rat vascular smooth muscle cells."J.Am.Soc.Nephrol.. 8(9). 333 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Akimoto, T., Kusano, E., Muto, S., Fujita, N., Okada, K., Komatsy, N., Ono, S., Homma, S., Ebata.S., Ando, Y., Saito, T., Asano, Y.: "The mechanism of inhibitory effect of muhan recombinant erythropoietin on nitric exide synthesis in interleukin 1 β-stimulated vascular smooth muscle cells."J.Am.Soc.Nephrol.. 9(9). 409A (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kusano, E., Akimoto, T., Fujita, N., Okada, K., Saito, O., Iimura, O., Amemiya, M., Ando, Y., Saito, T., Asano, Y.: "Human recombinant erythropoietin enhances cytosolic free calcium mobilizaion induced by vasoconstrictors in vascular smooth muscle cells."J.Am.Soc.Nephrol.. 9(9). 413A (1998)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Akimoto, T., Kusano, E., Ono, S., Ando, Y., Homma, S., Asano, Y.: "Regulation of cytosolic free calcium mobilization by erythropoietin in vascular smooth muscle cells."J.Am.Soc.Nephrol.. 10(9). 375A (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kusano, E., Akimoto, T., Muto, S., Ando, Y., Asano, Y.: "The effect of erythropoietin on IL-1 stimulated nitric oxide synthesis in vascular smooth muscle cells."J.Am.Soc.Nephrol.. 10(9). 383A (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kusano, E., Akimot, T., Iimura, O., Takahashi, H., Ito, C., Ando, Y., Asano Y.: "Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidy linositol 3 kinase-dependent pathway. Tronto, Oct. 10-16, 2000"J.Am.Soc.Nephrol.. 11. 459A (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kusano E: "Modulation of endothelin-1 induced cytosolic free calcium mobilization and mitogen-activated protein kinase activation by erythropoietin in vascula smooth muscle cells."Kidney and Blood pressure Res. (in press). (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Kusano E: "Hemodialysis and nitric oxide."J Artif Org. (in press). (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Akimoto T: "Involvement of erythropoietin induced cytosolic free calcium mobilization in activation of mitogen-activated protein kinase and DNA synthesis in vascular smooth muscle cells."J Hypertens. 19. 193-202 (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Akimoto T: "Erythropoietin modulates angiotensin II or norepinephrine induced Ca2+ mobilization in cultured rat vascular smooth muscle cells."Nephrol Dial Transplant. (in press). (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Sasaki N.: "Glucocorticoid decreases circulating osteoprotegerin (OPG): possible mechanism for glucocorticoid induced osteoporosis."Nephrol Dial Transplant. (in press). (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Akimot T: "Erythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathway."Kidney Int. 58. 269-282 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Akimoto T:: "Erythropoietin regulates vascular smooth muscle cell apoptosis byphosphatidylinositol 3-kinase dependent pathway"Kidney Int (in press). (2000)

    • Related Report
      1999 Annual Research Report
  • [Publications] Akimoto T:: "The effect of ervthropoietin on interleukin-1β mediated increase in nitric oxidesynthesis in vascular smooth muscle cells"J. Hypertens.. 17:. 1249-1256 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Umino T:: "AVP inhibits LPS-and IL-1β-stimulated NO and cGMP via V1 receptor in cultured rat mesangial cells"Am. J. Physiol. Renal Physiol. 45. F433-F441 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kusano E:: "Human recombinant ervthropoietin inhibits interleukin-1β stimulated nitric oxide and cyclic guanosine monophosphate production in cultured rat vascular smooth muscle cell"Nephrol Dial Transplant. 14. 597-603 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] 秋元 哲: "遺伝子組み替えヒトエリスロポエチンは血管収縮性因子による細胞内カルシウム上昇を増強する"第7回腎とエリスロポエチン研究会Proceedings,. 119-125 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] 秋元 哲: "血管平滑筋における誘導型一酸化窒素合成酵素(iNOS)に対する遺伝子組み替えヒトエリスロポエチン(rHuEPO)の影響"Ther Res. 20. 119-125 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] 秋元 哲: "透析療法New Wave東京"中外医学社. 10 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kusano E.et al.: "Human recombinant erythropoetin inhibits interleukin-1β-stimulator nitric oxide……" Nephrol.Dial.Transplant.(in press). 14. (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] Umino T et al.: "AVP inhibits LPS-and IL-1β-stimulated NO……." Am.J.Physiol.(Renal Physiol)in press. 276. (1999)

    • Related Report
      1998 Annual Research Report
  • [Publications] 草野英二 他: "エリスロポエチン使用と高血圧" 臨床透析(6月増刊号). 14. 121-130 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 草野英二 他: "エリスロポエチンの昇圧機序の検討" 腎性貧血研究会(平成9年度研究報告集). 67-72 (1998)

    • Related Report
      1998 Annual Research Report
  • [Publications] 秋元哲 他: "エリスロポエチンはインターロイキン-1(IL-1β)による一酸化窒素(NO)とcGMP" 腎とエリスロポエチン研究会Proceeding(印刷中). (1999)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi